(Total Views: 419)
Posted On: 01/16/2020 11:26:04 AM
Post# of 145915
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: thriftycents #15164
Lower price overseas, in some cases much less. Deal structures are usually 20% - 25% of sales (although with our large array of indications we might get 35% - 40%). This is offset by the larger patient population.
When I switched over to investing in biopharma I looked at a bunch of examples and doubling U.S. revenue would give you a rough ballpark figure for total revenue, although a bit on the low side.
When I switched over to investing in biopharma I looked at a bunch of examples and doubling U.S. revenue would give you a rough ballpark figure for total revenue, although a bit on the low side.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)